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C-reactive protein  (CRP)  is a  major human acute phase protein  composed of 
five identical,  21,500  mol wt subunits (1, 2). CRP is detectable on the surface of 
~4%  of normal  PBL.  CRP binds  its physiological  ligands  in  a  Ca++-dependent 
manner; removal of Ca  ++ does not alter the presence of CRP on the lymphocyte 
surface (3). Recently, investigators in this laboratory have reported (4) substantial 
inhibition  of NK activity  when  effector cells  were  treated  with  anti-CRP.  Al- 
though  the  liver is the  site of CRP production  contributing  to the  acute phase 
response (5), data presented here suggests that some iymphocytes produce small 
amounts  of CRP and  express  it  on  their  surface.  Surface  CRP  (S-CRP)  is  not 
acquired exogenously from trace levels of CRP in normal serum. 
Materials and  Methods 
Isolation of PBMC.  PBMC were separated from whole blood on Ficoll-Hypaque. They 
were  then  washed  and  resuspended  in  balanced  salt  solution  (BSS)  containing  0.05% 
gelatin. 
Enrichment  of PBL and  Large  Granular  Lymphocytes (LGL).  PBL  were  incubated  in 
RPMI containing 90%  FCS and  10 mg/ml carbonyl iron with rotation at 37°C  for 45 
rain.  Phagocytic cells were removed with  a  magnet.  Mononuclear phagocyte-depleted 
PBL were enriched for LGL by layering onto discontinuous  Percoll gradients (6).  The 
exact percentage of lymphocytes obtained from each Percoll layer varied with the donor. 
Anti-CRP Antibodies.  Immunoprecipitations were performed with sheep anti-CRP (lot 
20557;  Cappel  Laboratories,  Malvern,  PA).  Other  experiments were  performed  with 
purified  goat anti-CRP  IgG (American  Biosystems Laboratories,  Marine  of St.  Croix, 
MN). 
Labeling PBL with lZ~l-conjugated Antibodies.  Goat anti-CRP was iodinated  using the 
lactoperoxidase method (7).  Monocyte-depleted PBL were incubated with ~25I-anti-CRP 
for  30  min  at  37°C.  Antibody-labeled  cells  were  centrifuged  on  Percoll  gradients; 
lymphocytes were harvested and counted on a gamma counter. 
Anti-CRP Pretreatment of PBL.  PBL,  LGL or target cells were resuspended in RPMI 
containing 0.05% gelatin and incubated for 30 min at 37°C  in the presence or absence 
of various dilutions of anti-CRP. 
K562 Target Cells.  K562 cells used as target cells were labeled with 5LCr by incubating 
5  )<  10  6 cells/ml in RPMI containing 100 #Ci of 5~Cr at 37°C for 1 h. 
51Cr-release Assay.  A 4-h ~Cr-release assay using 5  ×  105 effector cells and  104 5tCr- 
labeled K562 were incubated in 0.2 ml RPMI containing 0.05% gelatin at 37°C. After 4 
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h, half(100/~1) of the supernatant was harvested, and percent specific release was calculated 
as 100  x  [(experimental release) -  (spontaneous release)l/[(detergent release) -  (sponta- 
neous release)]. 
Radiolabeling of S-CRP.  Cells were biosynthetically labeled with [35S]met (New England 
Nuclear,  Boston,  MA).  Cells  were  washed  three  times  with  met-free  DMEM  (M.  A. 
Bioproducts,  Walkersville,  MD)  and  resuspended  in  met-free  DMEM  containing  250 
#Ci/ml [~S]met, 2 mM glutamine,  100 ~zg/ml gentamycin, 5% IL-1, and 5% IL-2. ~3.5 
×  10 ~ cells  per  200  ttl  were  cultured  in  96-well  culture  plates  for  4  b.  Plates  were 
centrifuged at 200 g for 10 min; supernatants were collected and stored at -70 °C. Cells 
were lysed and frozen at -70°C. 
Immunoprecipitation  and  SDS-PAGE.  lmmunoprecipitations  were  performed  as  de- 
scribed by Sackstein and  Colton (8).  Radiolabeled cells were lysed with  200  ul  ice-cold 
lysis buffer, and  incorporation  of isotope into  total  protein  was assayed by cold TCA 
precipitation. 
Antibodies  were  added  to  cell  lysates  at  a  1:20  final  dilution,  and  mixtures  were 
incubated for I  h at room temperature or overnight at 4°C. To each sample,  100  t~l of 
fixed Staphylococcus aureus  (IgGsorb; The Enzyme Center,  Boston, MA) was added and 
incubated for 1 h at 4°C. The IgGsorb had been prepared as described by Auerbacb et 
al. (9). In all experiments, samples were precleared with 50 ul ofa 10% IgGsorb suspension. 
A preprecipitation reaction was also run with irrelevant antisera (sheep IgG fraction) to 
minimize nonspecific  binding  to relevant immunoprecipitates.  In some experiments,  a 
1:20 dilution ofanti-CRP was allowed to react with unlabeled human serum CRP. Blocked 
antibody was then used in the immunoprecipitation reactions, lmmunoprecipitates were 
washed six  times in  ice-cold lysis buffer and  prepared  for SDS-PAGE under  reducing 
conditions  as  described  by  Laemmli (10).  Gels  were  fixed,  stained,  and  treated  with 
Amplify (Amersham Corp., Arlington  Heights, IL) and dried.  Dried gels were exposed 
to x-ray film (Kodak XAR-5) at -70°C. 
Results 
S-CRP Is Not Bound  to  NK  Cells  in  a  Ca++-dependent Manner.  Since  earlier 
studies (4) have shown that NK activity could be inhibited by anti-CRP, the effect 
of EDTA on S-CRP and  NK activity was tested.  Normal blood was collected in 
either EDTA or heparin and examined for NK activity; cells collected in EDTA 
and  those  collected  in  heparin  had  identical  NK  activities.  Cells  collected  in 
either EDTA or heparin were tested for their reactivity with anti-CRP antibodies 
in a  standard 5~Cr-release assay. As shown in Fig.  1,  NK activity of both groups 
was significantly abrogated by anti-CRP,  suggesting that S-CRP is not removed 
from  the  lymphocyte  membrane  upon  removal  of Ca  ++.  These  results  are  in 
agreement with those of  James et al. (3), who showed that S-CRP is still detectable 
on lymphocytes after removal of Ca  ++. 
S-CRP Is Present on  LGL.  The  above and  previous data  (4)  suggest  that  S- 
CRP may be expressed on NK effectors. NK activity is attributed to LGL isolated 
from the low-density fractions of discontinuous  Percoll gradients (6). Monocyte- 
depleted PBL were treated with 125I-labeled anti-CRP antibodies (12~i_anti_CRP). 
~25I-anti-CRP-treated cells were then layered on Percoll gradients consisting of 
five layers ranging from 34 to 50%.  As seen in Table I, the majority of 125I was 
bound to cells in the uppermost low-density fractions. 
S-CRP Produced by Lymphocytes.  Although S-CRP could not be removed with 
EDTA, the possibility remained that S-CRP was acquired exogenously, and that 
its binding to lymphocytes was Ca  ++ independent.  PBMC,  PBL, and  LGL were 
incubated for 4  h  in met-free DMEM  supplemented with [35S]met.  Fig.  2  shows KUTA  AND  BAUM  BRIEF  DEFINITIVE  REPORT  323 
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FIGURE  1.  EDTA  collection  of lymphocytes does  not  affect  S-CRP  of NK  effector  cells. 
Although CRP-ligand  interactions are  Ca  ++ dependent and  fail  to occur in the  presence of 
EDTA, anti-CRP  inhibited NK-mediated killing of K562 by effectors collected  in EDTA or 
heparin. 
TABLE  I 
Separation  of lz~I-Labeled  Cells on PercoU Density Gradients 
Percoll fraction  ~251-Anti-CRP  Cells 
Exp.  (% Percoll)  (% recovered)  (% recovered) 
l  1 (34)  87  6 
2 (38)  3  26 
3 (42)  2  41 
4 (46)  2  16 
5 (50)  1  l0 
6 pellet  5  2 
2  1 (34)  63  4 
2 (38)  7  29 
3 (42)  2  45 
4 (46)  2  18 
5 (50)  1  2 
6 pellet  27  2 
PBL  were labeled  with  ~251-anti-CRP and  centrifuged  on  discontinuous  Percoll 
gradients. 
an autoradiograph of [35S]met-labeled  CRP subunits at ~21,500 mol wt (PBMC, 
PBL, and  LGL; lanes A, C, and E,  respectively). Experiments using unlabeled 
human serum  CRP  to  block  the  binding sites  of anti-CRP  antibodies  before 
immunoprecipitation show that cold CRP can reduce the amount of labeled S- 
CRP recovered (PBMC, PBL, and LGL; Fig. 2, lanes B, D, and F, respectively). 324  KUTA  AND  BAUM  BRIEF  DEFINITIVE  REPORT 
FIGURE 2.  S-CRP production by PBMC, PBL, and LGL. After a 4-h incubation, biosynthet- 
ically labeled S-CRP was detectable in cultures of PBMC, PBL, and LGL (lanes A, C, and E, 
respectively). When anti-CRP antibodies were blocked with cold CRP at a  1:6 (wt/wt) ratio, 
the amount of [s~S]met-labeled S-CRP recovered was reduced (PBMC,  PBL, and LGL; lanes 
B, D, and F, respectively). Each pair is from a separate experiment. 
Although  S-CRP production  by PBL and  LGL  was detectable,  it  was possible 
that  monocytes  were  contributing  to  the  S-CRP  produced  by  PBMC.  Fig.  3 
shows that,  while PBL and LGL produce S-CRP (middle and right lanes, respec- 
tively),  monocytes  do  not  (left  lane).  No  CRP  production  was  detectable  in 
monocyte  cultures.  In  addition,  biosynthetically  labeled  CRP  could  not  be 
detected in 4-h supernatants of lymphocyte cultures, suggesting that lymphocytes 
may not secrete CRP (data not shown). 
Discussion 
James et al. (3,  11) reported the presence of CRP on ~4% of hmnan  lympho- 
cytes.  We  have  previously  described  (4)  substantial  inhibition  of NK  activity 
when lymphocytes were treated with anti-CRP. This suggests that CRP is on the 
majority of lymphocytes that  function as NK effector cells. The data presented 
here  confirm  the  presence  of S-CRP on  certain  lymphocytes and  suggest  that 
lymphocytes can produce CRP. 
Great  quantities  of serum  CRP are  produced  by the  liver during  the  acute 
phase  response  (1,  5).  We  have  shown  that  lymphocytes produce  CRP  or  an 
immunologically crossreactive protein of ~21,500  mol  wt under reducing con- 
ditions.  This is the mol wt of CRP subunits (1).  We suggest that the same cells 
that produce S-CRP express this protein.  The production of serum proteins by 
both  hepatocytes,  and  to a  lesser  extent,  cells of hematopoietic  origin,  is well 
known (12-14).  Gahmberg and  Anderson  (13) described a  membrane  form of KUTA  AND  BAUM  BRIEF  DEFINITIVE  REPORT  325 
FIGURE 3.  Lack  of S-CRP  production by monocyte/macrophages.  PBMC  as  well as  PBL 
produced CRP.  Mononuclear phagocytes did not produce detectable S-CRP  (left),  PBL and 
Percoll-enriched LGL did produce S-CRP (middle and right,  respectively). 
the human acute phase protein oq-acid glycoprotein (AAG) on normal lympho- 
cytes and showed that the membrane form of AAG is produced by lymphocytes. 
The complement componant C3,  also an acute phase protein (1),  is produced 
primarily by the liver (12,  14); however, considerable C3 is produced by mono- 
cytes and macrophages (12,  14). 
Extrahepatic synthesis of CRP  could only be attributed  to  lymphocytes; no 
CRP  production by monocytes could be detected. This  is in concert with the 
findings  of  Kushner  and  Feldman  (15),  who  reported  CRP  production  by 
hepatocytes only;  no  CRP  synthesis could  be  attributed  to  the  mononuclear 
phagocytes of the liver. In addition, when immunoprecipitation was performed 
on  lymphocyte or monocyte culture supernatants,  no  CRP  was  found,  which 
suggests that the lymphocytes that produce CRP may not secrete it. 
Since the mol wt of CRP  subunits is similar to that of immunoglobulin light 
chains,  it  was  possible  that  anti-CRP  antibodies  were crossreacting with  light 
chains produced by B cells in the cultures. If this were the case, immunoprecip- 
itation of culture supernatants should detect secreted light chains, but none were 
detected. In addition, light chains on the stained, dried gels did not correspond 
to the labeled, 21,500 mol wt labeled proteins on the respective autoradiographs. 
Summary 
Biosynthetic  labeling  with  [35S]met  and  immunoprecipitation  with  anti-C- 
reactive  protein  (CRP)  antibodies  and  Staphylococcus  aureus  indicate  that  cell 
surface CRP is produced by lymphocytes. The ability ofanti-CRP to reduce NK 
activity, and  the demonstration  that  12~I-anti-CRP-labeled  PBL  are found in 
low-density Percoll fractions associated with  large granular lymphocyte (LGL) 
and NK activity suggest that S-CRP-bearing cells are NK effectors. The produc- 326  KUTA  AND  BAUM  BRIEF  DEFINITIVE REPORT 
tion of S-CRP by LGL supports this hypothesis.  While lymphocytes were shown 
to synthesize S-CRP, monocytes produced no detectable S-CRP. The lymphocytes 
that  produce  S-CRP  apparently  do  not  secrete  it;  when  lymphocyte  culture 
supernatants  were  tested,  no  S-CRP was found.  This  is the  first description  of 
extrahepatic synthesis of CRP. 
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